L
Selected References
- PDF / 295,388 Bytes
- 27 Pages / 595.28 x 790.87 pts Page_size
- 68 Downloads / 205 Views
L.K. Golightly et al. (eds.), Renal Pharmacotherapy, DOI 10.1007/978-1-4614-5800-5_11, © Springer Science+Business Media New York 2013
379
Dosage Adjustment of Medications Eliminated by the Kidneys
Lacosamide - Selected References Andurkar SV, Stables JP, Kohn H. The anticonvulsant activities of N-benzyl 3-methoxypropionamides. Bioorg Med Chem. 1999;7:2381–9. Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia. 2007;48:1308–17. Beyreuther BK, Callizot N, Brot MD, Feldman R, Bain SC, Stöhr T. Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain. Eur J Pharmacol. 2007;565:98–104. Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. Lacosamide: a review of preclinical properties. CNS Drug Rev. 2007;13:21–42. Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD. Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia. 2008;49:418–24. Chung S, Sperling MR, Biton V, et al. Lacosamide as adjunctive therapy for partial-onset seizures: a randomized controlled trial. Epilepsia. 2010;51:958–67. Costa J, Fareleira F, Ascenção R, Borges M, Sampaío C, Vaz-Carneiro A. Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis. Epilepsia. 2011;52:1280–91. Duncan GE, Kohn H. The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model. Epilepsy Res. 2005;67:81–7. Greenaway C, Ratnaraj N, Sander JW, Patsalos PN. Saliva and serum lacosamide concentrations in patients with epilepsy. Epilepsia. 2011;52:258–63. Halász P, Kälviäinen R, Mazurkiewicz-Beldzi ska M, et al. Adjunctive lacosamide for partial-onset seizures: efficacy and safety results from a randomized controlled trial. Epilepsia. 2009;50:443–53. Kelemen A, Halász P. Lacosamide for the prevention of partial onset seizures in epileptic adults. Neuropsychiatr Dis Treat. 2010.6:465–71. Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand. 2011;123:142–6. Krause LU, Brodowski KO, Kellinghaus C. Atrioventricular block following lacosamide intoxication. Epilepsy Behav. 2011;20:725–7. Łuszcki JJ. Third-generation antiepileptic drugs : mechanisms of action, pharmacokinetics and interactions. Pharmacol Rep. 2009;61:197–216. Maschio M, Dinapoli L, Mingoia M, et al. Lacosamide as add-on in brain tumor-related epilepsy : preliminary report on efficacy and tolerability. J Neurol. 2011;258(11):2100–4. doi:10.1007/s00415-011-6132-8. Nizam A, Mylavarapu K, Thomas T, et al. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia. 2011;52(10):e153–5. doi:10.1111/j.1528-1167.2011.03212.x. Parkerson KA, Reinsberger C, Cho
Data Loading...
